GlassScriptPhysician profile
Elizabeth A Root
NPI 1093856940
$1,668.38
in general payments reported to CMS, 2019-2025
26 companies · $33.84 in 2025
The $33.84 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $347 · 2022: $504 · 2023: $598 · 2024: $185 · 2025: $33.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $817.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $325.64 | 2021-2023 | |
| Aspira Women'S Health INC | $199.79 | 2022-2023 | Ova1 |
| Pfizer INC. | $190.80 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $177.26 | 2023-2024 | Myfembree |
| Astellas Pharma US INC | $96.31 | 2023-2024 | Veozah |
| Myovant Sciences INC. | $66.60 | 2022 | |
| Daiichi Sankyo INC. | $60.70 | 2022-2023 | Injectafer |
| Organon LLC | $59.15 | 2022-2023 | Nexplanon |
| Biogen, INC. | $53.39 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $40.41 | 2023 | |
| Coloplast Corp | $37.90 | 2023-2024 | Restorelle |
| Therapeuticsmd, INC. | $37.57 | 2021-2022 | |
| Exeltis, USA INC. | $36.30 | 2021-2022 | |
| Ascend Therapeutics US, LLC | $33.16 | 2021-2022 | |
| Hologic Sales and Service, LLC | $29.24 | 2023 | Acessa Provu System |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $26.22 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $24.25 | 2022 | |
| Merck Sharp & Dohme LLC | $22.84 | 2024 | Gardasil 9, Gardasil, Capvaxive |
| Coopersurgical, INC. | $22.57 | 2022 | |
| Alydia Health | $21.83 | 2021 | |
| Minerva Surgical, INC | $20.45 | 2023 | |
| Mayne Pharma Commercial LLC | $20.23 | 2022 | |
| Exact Sciences Corporation | $19.91 | 2023 | Cologuard Collection Kit |
| Lilly USA, LLC | $18.57 | 2022 | |
| Octapharma USA, INC. | $15.63 | 2025 | Fibryga |
| Agile Therapeutics, INC. | $11.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Root listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.